Gold fiducial markers (FMs) for prostate radiotherapy are commonly localized using Computed Tomography (CT), though interest in MR-only workflows is growing. One current limitation with magnitude-based MR-only workflows is the ability to distinguish FMs from blood products and calcifications because all appear as signal voids. Quantitative Susceptibility Mapping (QSM) separates sources based on their susceptibility, and may be a potential solution. We apply the QSMxT pipeline to gradient-echo images of a prostate cancer patient with FMs and a calcification. We found that QSM provided a contrast that could differentiate the FMs from calcifications to a degree comparable to CT.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords